European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 4 , Pages 420-423 , October 2008

Preservation for Future use of the Autologous Saphenous Vein during femoro-popliteal Bypass Surgery is Inexpedient

Received 11 March 2008 ,Accepted 7 June 2008.

References 

  1. Klinkert P, Post PN, Breslau PJ, et al. Saphenous vein versus PTFE for above-knee femoro-popliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004;27:357–362
  2. Yeager RA, Porter JM. Basic data underlying clinical decision-making in vascular surgery: arterial and prosthetic graft infection. Ann Vasc Surg. 1992;6:485–491
  3. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1–296
  4. Burger DHC, Kappetein PA, Bockel van de H, et al. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg. 2000;32:278–283
  5. Curi MA, Skelly CL, Meyerson SL, Woo DH, Desai TR, McKinsey JF, et al. Conduit choice for above-knee femoro-popliteal bypass grafting in patiens with limb-threatening ischemia. Ann Vasc Surg. 2002;16:95–101
  6. Michaels JA. Choice of material for above-knee femoro-popliteal bypass graft. Br J Surg. 1989;76:7–14
  7. Sterpetti AV, Schultz RD, Feldhaus RJ, et al. Seven-year experience with polytetrafluoroethylene as above-knee femoro-popliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?. J Vasc Surg. 1985;2:907–912
  8. Giannoglou G, Kouzi-Koliakou N, Kanellaki-Kiparissi M, Kazinakis G, Nouskas I, Kerameos-Foroglou C, et al. Suitability of venous and arterial conduits used for coronary artery bypass grafting in conjunction with coronary disease risk factors. Int J Cardiol. 2001;80:61–68
  9. Goldman KA, Su WT, Riles TS, et al. A comparative study of saphenous vein, internal jugular vein and knitted dacron patches for carotid artery endarterectomy. Ann Vasc Surg. 1995;9:71–79
  10. Aburahma AF, Robinson PA, Saiedy S, et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. J Vasc Surg. 1998;27:222–232
  11. Scharn DM, Dirven M, Barendregt WB, et al. Human umbilical vein versus heparin-bonded polyester for femoro-popliteal bypass: 5-year results of a prospective randomized multicenter trial. Eur J Vasc Endovasc Surg. 2008;35:61–67
  12. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517–538
  13. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg. 2000;32:268–277
  14. Klinkert P, Schepers A, Burger , et al. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003;37:149–155
  15. Parker HJ, Fell G, Devine TJ, et al. Femoro-popliteal bypass using autogenous vein and modified human umbilical vein. A comparative study. J Cardiovasc Surg (Torino). 1988;29:727–732
  16. Johnson JA, Cogbill TH, Strutt PJ, et al. Wound complications after femoro-popliteal bypass: classification, predisposing factors and management. Arch Surg. 1988;123:859–862
  17. Devine C, McCollum C. Heparin-bonded Dacron or polytetrafluorethylene for femoro-popliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg. 2004;40(5):924–931
  18. Abbott WM, Green RM, Matsumoto T, Wheeler JR, Miller N, Veith FJ, et al. Prosthetic above-knee femoro-popliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoro-popliteal Study Group. J Vasc Surg. 1997;25:19–28
  19. Arnold TE, Kerstein MD. Secondary distal extension of femoro-popliteal bypass: long-term limb and patient survival. Ann Vasc Surg. 2000;14:450–456
  20. Chew KW, Owens CD, Belkin M, Donaldson MC, Whittemore AD, Mannick JA, et al. Bypass in the absence of ipsilateral greater Saphenous vein: safety and superiority of the contralateral greater Saphenous vein. J Vasc Surg. 2002;35:1085–1092
  21. Biancari F, Kangasniemi O-P, Mahar MAA, et al. Need for late lower limb revascularisation and major amputation after coronary artery bypass surgery. Eur J Vasc Endovasc Surg. 2008;35:596–602
  22. Houser SL, Hashmi FH, Jaeger VJ, et al. Should the greater saphenous vein be preserved in patients requiring arterial outflow reconstructions in the lower extremity?. Surgery. 1984;95:467–472
  23. Poletti LF, Matsuura JH, Dattilo JB, Posner MP, Lee HM, Scouvart M, et al. Should vein be saved for future operations? A 15-year review of femoro-popliteal bypasses and the subsequent need for autologous vein. Ann Vasc Surg. 1998;12:143–147

PII: S1078-5884(08)00335-3

doi: 10.1016/j.ejvs.2008.06.012

European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 4 , Pages 420-423 , October 2008

Article Tools

* Image Usage & Resolution